Clinical Trial

Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students

Study acronym: HPV-ADO
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 8, 2024 (before its estimated April 23, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective pragmatic study to assess the impact of a HPV vaccination talk in secondary school on actual vaccine dispensing in test communes compared with control communes. The talk consist on a briefing on the importance of vaccination. This is a controlled study, since two communes will benefit from the HPV vaccination talk, while the other two will serve as controls without set up of the HPV vaccination talk. The set up of this presentation will be open-label.
Trial Details
NCT Number NCT06631794
Lead Sponsor Hopital Foch
Collaborators: Agence Regionale de Sante d'Ile de France, Ospharm coopérative, French Interregional Group of Clinical Research and Innovation, Communauté professionnelle territoriale de santé
Conditions Teenagers
Enrollment 1,170 participants
Start Date 2024-10-23
Primary Completion 2025-04-23 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-08